These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration. Bertoni C; Jarrahian S; Wheeler TM; Li Y; Olivares EC; Calos MP; Rando TA Proc Natl Acad Sci U S A; 2006 Jan; 103(2):419-24. PubMed ID: 16387861 [TBL] [Abstract][Full Text] [Related]
7. Sarcoglycans take center stage in gene transfer therapy. Müller OJ; Lochmüller H Neurology; 2008 Jul; 71(4):234-5. PubMed ID: 18525030 [No Abstract] [Full Text] [Related]
8. Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy. Heydemann A; McNally EM Trends Cardiovasc Med; 2007 Feb; 17(2):55-9. PubMed ID: 17292047 [TBL] [Abstract][Full Text] [Related]
14. Gene therapy for muscular dystrophy: current progress and future prospects. Trollet C; Athanasopoulos T; Popplewell L; Malerba A; Dickson G Expert Opin Biol Ther; 2009 Jul; 9(7):849-66. PubMed ID: 19527108 [TBL] [Abstract][Full Text] [Related]
15. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders. English KM; Gibbs JL Dev Med Child Neurol; 2006 Mar; 48(3):231-5. PubMed ID: 16483403 [TBL] [Abstract][Full Text] [Related]
16. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP; Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086 [TBL] [Abstract][Full Text] [Related]
17. Utility of dystrophin and utrophin staining in childhood muscular dystrophy. Sundaram C; Vydehi B; Meena K; Murthy J Indian J Pathol Microbiol; 2004 Jul; 47(3):367-9. PubMed ID: 16295426 [TBL] [Abstract][Full Text] [Related]
18. Cardiac involvement in muscular dystrophy: advances in diagnosis and therapy. Yilmaz A; Sechtem U Heart; 2012 Mar; 98(5):420-9. PubMed ID: 22311853 [No Abstract] [Full Text] [Related]
19. [Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies]. Murakami T; Nishino I Brain Nerve; 2008 Oct; 60(10):1159-64. PubMed ID: 18975603 [TBL] [Abstract][Full Text] [Related]
20. Dystrophinopathy carrier determination and detection of protein deficiencies in muscular dystrophy using lentiviral MyoD-forced myogenesis. Cooper ST; Kizana E; Yates JD; Lo HP; Yang N; Wu ZH; Alexander IE; North KN Neuromuscul Disord; 2007 Apr; 17(4):276-84. PubMed ID: 17303423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]